- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05214833
Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback (NF-Agency)
March 21, 2022 updated by: Giuseppe Angelo Zito, ETH Zurich
This study investigates whether the sense of agency is sensitive to self-regulation by means of EEG-based neurofeedback.
During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants.
The participants can therefore use this information to adapt their performance on the motor task.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
225
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8057
- Recruiting
- ETH Zurich
-
Contact:
- Giuseppe A Zito, PhD
- Phone Number: +41766691816
- Email: zito.giuseppe.angelo@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria (all):
- Aged > 18 years old
- Normal or corrected-to-normal visual acuity
- Willing to participate in the study (by signing the informed consent form)
- Neither caffein, nor alcohol intake 48 hours prior to the experiment
- Regular intake of drugs (except oral contraceptives in women)
- Employed by, or in a dependent relationship with, the sponsor and / or the investigator(s)
- Sufficient knowledge of German or English to understand study documents and instructions.
Inclusion Criteria (patients):
- A diagnosis of temporal epilepsy (TE), documented via video EEG. OR
- A diagnosis of psychogenic non-epileptic seizure (PNES), according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and documented via video EEG.
Exclusion Criteria (all):
- Past surgery in the brain
- History of alcohol or drug abuse
- Incompatibility with EEG recordings, e.g., inability to stay seated for 90 minutes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real neurofeedback
The first arm will receive real neurofeedback.
|
During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants.
|
|
Sham Comparator: Sham neurofeedback
The second arm will receive sham neurofeedback.
|
During sham neurofeedback, a signal which resembles the participant's brain activity is used instead of the actual brain activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Electrophysiological data, i.e., EEG power in alpha band
Time Frame: Before and immediately after neurofeedback
|
Brain activity
|
Before and immediately after neurofeedback
|
|
Change in Electrophysiological data, i.e., EEG power in theta band
Time Frame: Before and immediately after neurofeedback
|
Brain activity
|
Before and immediately after neurofeedback
|
|
Change in Electrophysiological data, i.e., EEG power in gamma band
Time Frame: Before and immediately after neurofeedback
|
Brain activity
|
Before and immediately after neurofeedback
|
|
Change in the subjective perception of the Sense of Agency, i.e., visual analog scale assessing how much control participants feel over the game
Time Frame: Before and immediately after neurofeedback
|
Behavioural performance in response to manipulation of the Sense of Agency (SoA)
|
Before and immediately after neurofeedback
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age in years
Time Frame: Before neurofeedback
|
Baseline variable
|
Before neurofeedback
|
|
Sex (male/female)
Time Frame: Before neurofeedback
|
Baseline variable
|
Before neurofeedback
|
|
Years of education
Time Frame: Before neurofeedback
|
Baseline variable
|
Before neurofeedback
|
|
Medication status
Time Frame: Before neurofeedback
|
Baseline variable, list of drugs currently in use by the participant
|
Before neurofeedback
|
|
Anxiety
Time Frame: Before neurofeedback
|
Baseline variable assessed with the State-Trait Anxiety Inventory (STAI).
Minimum value (20) = no anxiety.
Maximum value (80) = high anxiety.
|
Before neurofeedback
|
|
Mood
Time Frame: Before neurofeedback
|
Baseline variable assessed with a visual analog scale.
Minimum value (0) = bad mood.
Maximum value (100) = good mood.
|
Before neurofeedback
|
|
Sleep habits
Time Frame: Before neurofeedback
|
Baseline variable assessed with the Pittsburgh Sleep Quality Index (PSQI).
Minimum value (0) = good sleep quality.
Maximum value (20) = poor sleep quality.
|
Before neurofeedback
|
|
Daily rate of cigarettes
Time Frame: Before neurofeedback
|
Baseline variable assessed in number of cigarettes/day
|
Before neurofeedback
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Anticipated)
January 31, 2025
Study Completion (Anticipated)
January 31, 2025
Study Registration Dates
First Submitted
November 30, 2021
First Submitted That Met QC Criteria
January 17, 2022
First Posted (Actual)
January 31, 2022
Study Record Updates
Last Update Posted (Actual)
April 1, 2022
Last Update Submitted That Met QC Criteria
March 21, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-02093
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI); WestatRecruiting
-
Chulalongkorn UniversityMae Fah Luang UniversityNot yet recruitingHealth, Subjective
-
Chulalongkorn UniversityNot yet recruiting
-
Prince Sattam Bin Abdulaziz UniversityCompletedHealth, SubjectiveSaudi Arabia
-
Çankırı Karatekin UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompleted
-
Hebrew SeniorLifeCompletedHealth, Subjective
-
Istanbul University - CerrahpasaRecruiting
-
Bahçeşehir UniversityNot yet recruiting
-
Alteogen, Inc.CompletedHealth, SubjectiveSouth Korea
Clinical Trials on Real Neurofeedback
-
Philipp StämpfliCompleted
-
Pedro MorgadoHospital de Braga; Clinical Academic Center (2CA)UnknownObsessive-Compulsive Disorder | OCDPortugal
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorder | Opioid Use Disorder | Heroin Use DisorderUnited States
-
Kymberly YoungNational Institute of Mental Health (NIMH)Terminated
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedMajor Depressive DisorderUnited States
-
Trustees of Princeton UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Icahn School of Medicine at Mount SinaiRecruiting
-
University of PennsylvaniaRecruiting
-
University of Electronic Science and Technology...Completed
-
University of Electronic Science and Technology...Recruiting